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Background/introduction
Melanoma has a 5-year survival rate of <10%, primarily
due to therapeutic resistance and immune tolerance.
Durable responses to therapy of metastatic melanoma are
enhanced when the anti tumor immune response is acti-
vated. FUS is an emerging non-invasive treatment modal-
ity for localized treatment of cancers. Traditionally FUS
has been used exclusively for thermal ablation of the target
sites; biological responses associated with both thermal
and mechanical damage have not been investigated.
Damaged tumor cells have release endogenous danger sig-
nals, which stimulate an immune response, suggesting that
the patient’s dying cancer cells may serve as a therapeutic
vaccine which stimulates an antitumor immune response.
Specifically, we hypothesize that FUS will augment tumor
antigen release and danger signals to mediate rejection of
both FUS treated and untreated tumors.
Methods
Studies using C57BL6 mice inoculated subcutaneously with
B16 melanoma cells were approved by the institutional ani-
mal care and use committee. When tumors became palp-
able, 100 cycles of 1MHz ultrasound was applied to the
tumor every 5 seconds for 5, 10 or 20 minutes. Following
treatment, tumor growth, survival, necrosis, and apoptosis
were measured. Tumor volume was evaluated by taking
daily measurements with digital calibers. Standard H & E
staining was performed to evaluate histological changes
that may have occurred as a result of the ultrasound expo-
sures. The detection of apoptotic cells was performed
using staining for Caspase 3.
Results and conclusions
Tumors harvested 3 days after treatment were analyzed
using H & E and caspase 3 staining. Staining with H & E
indicated that significantly more necrotic tissue was pre-
sent in all tumors treated with ultrasound. Staining for
Caspase 3 exhibited more extensive apoptosis in all treat-
ment groups when compared to untreated tumors.
Furthermore we found that ultrasound treatment dra-
matically decreased tumor size.
1 MHz ultrasound with low duty cycle can inhibits mel-
anoma tumor. We will use this platform to characterize
the immune response in treated tumors. We also plan to
combine microbubbles with ultrasound to see if there is a
synergistic effect on inhibition of tumor growth.
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